Genèse d’un site d’information sur le bon usage du médicament au cours de la pandémie - 21/10/20
Development of an information website on the proper use of medicines during the pandemic
Société française de pharmacologie et de thérapeutique
Société savante1
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
| pagine | 6 |
| Iconografia | 6 |
| Video | 0 |
| Altro | 0 |
Riassunto |
Dans le contexte de la Covid-19, la Société française de pharmacologie et de thérapeutique a ouvert, dès le 17 mars 2020, un site de questions-réponses pour répondre de façon claire et fiable aux interrogations des patients concernant le traitement de leurs pathologies chroniques, informer le grand public sur le bon usage du médicament et lutter contre la désinformation. Le 13 mai, 152 questions-réponses étaient publiées et mises à jour sur ce site qui avait reçu plus de 154 000 visites en deux mois.
Il testo completo di questo articolo è disponibile in PDF.Development of an information website on the proper use of medicines during the pandemic |
In the context of COVID-19, the French Society of Pharmacology and Therapeutics opened a question-and-answer website on 17 March 2020 to provide clear and reliable answers to patients’ questions about the treatment of their chronic pathologies, to inform the general public about the proper use of medicines and to fight against misinformation. On May 13, 152 questions and answers were published and updated on this website, which was visited more than 154,000 times in two months.
Il testo completo di questo articolo è disponibile in PDF.Mots clés : bon usage du médicament, Covid-19, essai clinique, hydroxychloroquine
Keywords : clinical trial, COVID-19, hydroxychloroquine, proper use of medicines
Mappa
Vol 59 - N° 599
P. 34-39 - Ottobre 2020 Ritorno al numero
Articolo precedente
- Covid-19, prise en charge, pistes thérapeutiques et vaccinales
- Élodie Matusik, Mériam Ayadi, Nicolas Picard
- Réflexions sur la crise sanitaire à l’officine
- Jérôme Sicard
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?